About ALTG

The Australasian Lung Cancer Trials Group (ALTG) is Australia and New Zealand's lung and thoracic cancer clinical research group. The ALTG is a multi-disciplinary organization dedicated to reducing the incidence, morbidity and mortality of lung and other thoracic cancers and improving the quality of life of these patients, carers and families in Australia and New Zealand through the coordination and facilitation of high quality clinical research.

The ALTG collaborates with a number of organizations including the NHMRC Clinical Trials Centre (CTC) and Peter MacCallum Cancer Centre. Both of these groups are leaders in Australia for the design, conduct, analysis and publication of oncology clinical trials, including working with both Australia and international collaborative groups.

Why become a member

  • Quarterly newsletter
  • Support
    for the development of investigator-initiated studies
  • Access to a professional network
    for lung and thoracic cancer research, including clinicians, nursing staff, industry affiliates and consumer representatives

Upcoming Events

6 March 2017 12.00am TACT Board Teleconference (closed)
24 March 2017 12.00am TSANZRS Annual Scientific Meeting, Canberra ACT
5 May 2017 12.00am ELCC, Geneva Switzerland